Medix Biochemica is pleased to return to ADLM 2026. We look forward to meeting with customers, exploring new collaborations, and presenting our comprehensive portfolio of in vitro diagnostic raw materials and tailored services.
Main booth: #3361 – Visit us to learn about our latest developments, access scientific and technical resources, and discuss how we can support your diagnostic assay development.
Medix Biochemica announces a $5 million investment to expand our recombinant antigen capabilities!
You are also welcome to visit our nearby secondary booth (#3367) dedicated to our recombinant antigen offering.
We look forward to meeting you at ADLM 2026.
Place: Anaheim Convention Center, Anaheim, California, USA
Dates: July 26 – July 30, 2026
Booths: 3361 (main booth) & 3367 (Recombinant Antigen booth)
Please book a meeting with us beforehand to discuss how we can support you with our extensive range of products and services.